These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8775097)

  • 1. [Toxicology and clinical significance of base-catalized degradation of sevoflurane to Compound A].
    Jones RM; Conzen P
    Anaesthesist; 1996 Feb; 45 Suppl 1():S10-3. PubMed ID: 8775097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative differences in the production and toxicity of CF2=BrCl versus CH2F-O-C(=CF2)(CF3) (compound A): the safety of halothane does not indicate the safety of sevoflurane.
    Eger EI; Ionescu P; Laster MJ; Gong D; Weiskopf RB; Kerschmann RL
    Anesth Analg; 1997 Nov; 85(5):1164-70. PubMed ID: 9356119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluoride-induced nephrotoxicity: factor fiction?].
    Nuscheler M; Conzen P; Schwender D; Peter K
    Anaesthesist; 1996 Feb; 45 Suppl 1():S32-40. PubMed ID: 8775101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal toxicity with sevoflurane: a storm in a teacup?
    Gentz BA; Malan TP
    Drugs; 2001; 61(15):2155-62. PubMed ID: 11772127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
    Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
    Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the renal cysteine conjugate beta-lyase pathway in inhaled compound A nephrotoxicity in rats.
    Kharasch ED; Hoffman GM; Thorning D; Hankins DC; Kilty CG
    Anesthesiology; 1998 Jun; 88(6):1624-33. PubMed ID: 9637657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate and toxicity of 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived mercapturates in male, Fischer 344 rats.
    Uttamsingh V; Iyer RA; Baggs RB; Anders MW
    Anesthesiology; 1998 Nov; 89(5):1174-83. PubMed ID: 9822006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sevoflurane].
    Gilsanz F; Celemín R; Blanc G; Orts MM
    Rev Esp Anestesiol Reanim; 1996; 43(7):243-8. PubMed ID: 8966352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrotoxicity and fluoride from the viewpoint of the nephrologist].
    Bosch T
    Anaesthesist; 1996 Feb; 45 Suppl 1():S41-5. PubMed ID: 8775102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sevoflurane on the metabolism and renal effects of compound A in rats.
    Kharasch ED; Schroeder JL; Sheffels P; Liggitt HD
    Anesthesiology; 2005 Dec; 103(6):1183-8. PubMed ID: 16306730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of compound A in rats. Effect of increasing duration of administration.
    Gonsowski CT; Laster MJ; Eger EI; Ferrell LD; Kerschmann RL
    Anesthesiology; 1994 Mar; 80(3):566-73. PubMed ID: 7908177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of a sevoflurane degradation product incubated with rat liver and renal cortical slices.
    Catania JM; Parrish AR; Gandolfi AJ
    Drug Chem Toxicol; 2001 Nov; 24(4):347-57. PubMed ID: 11665648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uptaken distribution and metabolism of sevoflurane].
    Dudziak R; Vettermann J
    Anaesthesist; 1996 Feb; 45 Suppl 1():S1-9. PubMed ID: 8775096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical evidence against the involvement of cysteine conjugate beta-lyase in compound A nephrotoxicity in rats.
    Njoku DB; Pohl LR; Sokoloski EA; Marchick MR; Borkowf CB; Martin JL
    Anesthesiology; 1999 Feb; 90(2):458-69. PubMed ID: 9952153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and toxicity of the new anesthetic agents.
    Kharasch ED
    Acta Anaesthesiol Belg; 1996; 47(1):7-14. PubMed ID: 8651050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sevoflurane, fluoride ion, and renal toxicity.
    Tinker JH; Baker MT
    Anesthesiology; 1995 Jul; 83(1):232-5. PubMed ID: 7605016
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cardiovascular effects of sevoflurane].
    Rolf N; Van Aken H
    Anaesthesist; 1996 Feb; 45 Suppl 1():S14-21. PubMed ID: 8775098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaminophen predisposes to renal and hepatic injury from compound A in the fasting rat.
    Laster MJ; Gong D; Kerschmann RL; Eger EI; Martin JL
    Anesth Analg; 1997 Jan; 84(1):169-72. PubMed ID: 8989019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of compound A in rats. Effect of a 3-hour administration.
    Gonsowski CT; Laster MJ; Eger EI; Ferrell LD; Kerschmann RL
    Anesthesiology; 1994 Mar; 80(3):556-65. PubMed ID: 8141452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response to a sevoflurane degradation product in the guinea pig following inhalation exposure.
    Zheng XH; Begay C; Lind RC; Gandolfi AJ
    Drug Chem Toxicol; 2001 Nov; 24(4):339-46. PubMed ID: 11665647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.